DeLuca Richard R.

EVP&Pres, Merck Animal Heallth

DeLuca Richard R. has filed 5 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.

On the most recent filing, DeLuca Richard R. is listed as EVP&Pres, Merck Animal Heallth at Merck & Co., Inc. Inside the rolling window, DeLuca Richard R. reported no open-market purchases and 5 open-market sales totaling $11.3M in MRK. The largest disclosed transaction in the window is a sale of 37,685 MRK shares on Feb 6, 2026, worth $4.6M.

Companies traded

Other insiders at MRK

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$11.3M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MRKSale$2.7MAug 12SEC ↗
MRKSale$1.7MAug 12SEC ↗
MRKSale$1.5MAug 12SEC ↗
MRKSale$789KAug 10SEC ↗
MRKSale$4.6MFeb 6SEC ↗
Showing 1–5 of 5
1 / 1

Frequently asked questions

How many SEC Form 4 filings has DeLuca Richard R. made?

DeLuca Richard R. has filed 5 SEC Form 4 filings (12 transaction rows) across 1 company since 2026.

Which companies does DeLuca Richard R. trade?

DeLuca Richard R. has filed SEC Form 4 disclosures for 1 company, including MRK.

When was DeLuca Richard R.'s most recent SEC Form 4 filing?

DeLuca Richard R.'s most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.

What is DeLuca Richard R.'s job title?

On the most recent SEC Form 4 filings tracked by Tracefour, DeLuca Richard R. is listed as EVP&Pres, Merck Animal Heallth.

What is DeLuca Richard R.'s total buy and sell value in the current window?

Inside the rolling retention window, DeLuca Richard R. bought $0 and sold $11.3M based on SEC Form 4 filings.

What was DeLuca Richard R.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 37,685 MRK shares on 2026-02-06, worth $4.6M, per SEC Form 4 filings.